News
The U.S. Department of Health and Human Services announced on August 5, 2025, that the coordinated programs of mRNA vaccine development under the Biomedical Advanced Research and ...
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
1h
Barchart on MSNModerna Stock: Is Wall Street Bullish or Bearish?With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...
The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like Covid-19 and the flu. Robert F ...
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...
The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...
In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...
Discover key takeaways from Moderna's Q2 2025 earnings call, including FDA approvals, cost reductions, pipeline strategies, and financial updates.
Nevertheless, Moderna has lowered its revenue guidance for the year by $300 million. The company now expects to generate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results